These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 2540776)

  • 41. Tumor necrosis factor receptor-mediated signaling pathways.
    Heller RA; Krönke M
    J Cell Biol; 1994 Jul; 126(1):5-9. PubMed ID: 8027185
    [No Abstract]   [Full Text] [Related]  

  • 42. The tumor necrosis factors: cachectin and lymphotoxin.
    Beutler B
    Hosp Pract (Off Ed); 1990 Feb; 25(2):45-56. PubMed ID: 2105975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cachectin: its impact on metabolism and nutritional status.
    Moldawer LL; Lowry SF; Cerami A
    Annu Rev Nutr; 1988; 8():585-609. PubMed ID: 3060179
    [No Abstract]   [Full Text] [Related]  

  • 44. The biochemistry and pharmacology of TNF alpha and beta, 21 April 1995, New York.
    Carty TJ; Gilman SC
    Inflamm Res; 1995 Nov; 44(11):455-7. PubMed ID: 8597876
    [No Abstract]   [Full Text] [Related]  

  • 45. The history, properties, and biological effects of cachectin.
    Beutler B; Cerami A
    Biochemistry; 1988 Oct; 27(20):7575-82. PubMed ID: 3061461
    [No Abstract]   [Full Text] [Related]  

  • 46. Tumour necrosis factors in clinical practice.
    Goh CR
    Ann Acad Med Singap; 1990 Mar; 19(2):235-9. PubMed ID: 2189343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition.
    Pfizenmaier K; Krönke M; Scheurich P; Nagel GA
    Blut; 1987 Jul; 55(1):1-10. PubMed ID: 3038218
    [No Abstract]   [Full Text] [Related]  

  • 48. Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation.
    Beutler B; Cerami A
    Immunol Res; 1986; 5(4):281-93. PubMed ID: 3036973
    [No Abstract]   [Full Text] [Related]  

  • 49. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.
    Sherry B; Cerami A
    J Cell Biol; 1988 Oct; 107(4):1269-77. PubMed ID: 3049617
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug therapy: smuggling trastuzumab into the brain.
    Villanueva MT
    Nat Rev Clin Oncol; 2013 Dec; 10(12):669. PubMed ID: 24165949
    [No Abstract]   [Full Text] [Related]  

  • 51. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.
    Vilcek J; Lee TH
    J Biol Chem; 1991 Apr; 266(12):7313-6. PubMed ID: 1850405
    [No Abstract]   [Full Text] [Related]  

  • 52. [Is cachectin TNF?].
    Kawakami M
    Seikagaku; 1987 Nov; 59(11):1244-7. PubMed ID: 3449576
    [No Abstract]   [Full Text] [Related]  

  • 53. Tuberculosis in otherwise healthy adults with inherited TNF deficiency.
    Arias AA; Neehus AL; Ogishi M; Meynier V; Krebs A; Lazarov T; Lee AM; Arango-Franco CA; Yang R; Orrego J; Corcini Berndt M; Rojas J; Li H; Rinchai D; Erazo-Borrás L; Han JE; Pillay B; Ponsin K; Chaldebas M; Philippot Q; Bohlen J; Rosain J; Le Voyer T; Janotte T; Amarajeeva K; Soudée C; Brollo M; Wiegmann K; Marquant Q; Seeleuthner Y; Lee D; Lainé C; Kloos D; Bailey R; Bastard P; Keating N; Rapaport F; Khan T; Moncada-Vélez M; Carmona MC; Obando C; Alvarez J; Cataño JC; Martínez-Rosado LL; Sanchez JP; Tejada-Giraldo M; L'Honneur AS; Agudelo ML; Perez-Zapata LJ; Arboleda DM; Alzate JF; Cabarcas F; Zuluaga A; Pelham SJ; Ensser A; Schmidt M; Velásquez-Lopera MM; Jouanguy E; Puel A; Krönke M; Ghirardello S; Borghesi A; Pahari S; Boisson B; Pittaluga S; Ma CS; Emile JF; Notarangelo LD; Tangye SG; Marr N; Lachmann N; Salvator H; Schlesinger LS; Zhang P; Glickman MS; Nathan CF; Geissmann F; Abel L; Franco JL; Bustamante J; Casanova JL; Boisson-Dupuis S
    Nature; 2024 Sep; 633(8029):417-425. PubMed ID: 39198650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mononuclear Phagocytes, Cellular Immunity, and Nobel Prizes: A Historic Perspective.
    Gordon S; Roberti A; Kaufmann SHE
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
    Mazziotti V; Crescenzo F; Turano E; Guandalini M; Bertolazzo M; Ziccardi S; Virla F; Camera V; Marastoni D; Tamanti A; Calabrese M
    J Neuroinflammation; 2024 Aug; 21(1):209. PubMed ID: 39169320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kumujan B suppresses TNF-α-induced inflammatory response and alleviates experimental colitis in mice.
    Li X; Di Q; Li X; Zhao X; Wu H; Xiao Y; Tang H; Huang X; Chen J; Chen S; Gao Y; Gao J; Xiao W; Chen W
    Front Pharmacol; 2024; 15():1427340. PubMed ID: 39148547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets.
    Li L; Lu J; Liu J; Wu J; Zhang X; Meng Y; Wu X; Tai Z; Zhu Q; Chen Z
    Front Immunol; 2023; 14():1340677. PubMed ID: 38239345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PNAd-expressing vessels characterize the dermis of CD3+ T-cell-mediated cutaneous diseases.
    Budair FM; Nomura T; Hirata M; Kabashima K
    Clin Exp Immunol; 2024 Mar; 216(1):80-88. PubMed ID: 38227774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of histopathology and changes of major cytokines in the lesions caused by Mycoplasma ovipneumoniae infection.
    Li J; Chen C; Gao L; Wang L; Wang W; Zhang J; Gong Z; Wang J; Guo Y
    BMC Vet Res; 2023 Dec; 19(1):273. PubMed ID: 38102682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vitro Assessment of Anti-Adipogenic and Anti-Inflammatory Properties of Black Cumin (
    Bashir KMI; Kim JK; Chun YS; Choi JS; Ku SK
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.